1. Home
  2. PRAX vs LSTR Comparison

PRAX vs LSTR Comparison

Compare PRAX & LSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRAX
  • LSTR
  • Stock Information
  • Founded
  • PRAX 2015
  • LSTR 1991
  • Country
  • PRAX United States
  • LSTR United States
  • Employees
  • PRAX N/A
  • LSTR N/A
  • Industry
  • PRAX Biotechnology: Pharmaceutical Preparations
  • LSTR Trucking Freight/Courier Services
  • Sector
  • PRAX Health Care
  • LSTR Industrials
  • Exchange
  • PRAX Nasdaq
  • LSTR Nasdaq
  • Market Cap
  • PRAX 4.0B
  • LSTR 4.2B
  • IPO Year
  • PRAX 2020
  • LSTR 1993
  • Fundamental
  • Price
  • PRAX $178.75
  • LSTR $129.48
  • Analyst Decision
  • PRAX Strong Buy
  • LSTR Hold
  • Analyst Count
  • PRAX 13
  • LSTR 13
  • Target Price
  • PRAX $202.85
  • LSTR $145.91
  • AVG Volume (30 Days)
  • PRAX 1.4M
  • LSTR 445.2K
  • Earning Date
  • PRAX 11-07-2025
  • LSTR 10-28-2025
  • Dividend Yield
  • PRAX N/A
  • LSTR 2.77%
  • EPS Growth
  • PRAX N/A
  • LSTR N/A
  • EPS
  • PRAX N/A
  • LSTR 4.77
  • Revenue
  • PRAX $7,765,000.00
  • LSTR $4,802,153,000.00
  • Revenue This Year
  • PRAX N/A
  • LSTR $1.59
  • Revenue Next Year
  • PRAX $20.00
  • LSTR $8.39
  • P/E Ratio
  • PRAX N/A
  • LSTR $27.21
  • Revenue Growth
  • PRAX 338.45
  • LSTR N/A
  • 52 Week Low
  • PRAX $26.70
  • LSTR $119.32
  • 52 Week High
  • PRAX $205.89
  • LSTR $196.86
  • Technical
  • Relative Strength Index (RSI)
  • PRAX 80.27
  • LSTR 51.67
  • Support Level
  • PRAX $164.75
  • LSTR $127.08
  • Resistance Level
  • PRAX $192.96
  • LSTR $138.14
  • Average True Range (ATR)
  • PRAX 11.99
  • LSTR 4.80
  • MACD
  • PRAX 13.57
  • LSTR 0.98
  • Stochastic Oscillator
  • PRAX 82.53
  • LSTR 48.45

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

About LSTR Landstar System Inc.

Landstar System is an agent based asset-light third-party logistics provider focused on domestic truck brokerage. Historically, around half of its truck transportation freight is hauled by leased owner-operators with the remainder hauled by third-party broker-carriers. To a smaller degree, it offers intermodal, global air and ocean forwarding, and warehousing services. Landstar also runs a small business that offers insurance programs to captive owner-operators. It has a long history of industry-leading execution and operating profitability.

Share on Social Networks: